RocketTickers

Astellas and Pfizer Announce Positive Top-Line Results

Long
NYSE:PFE   Pfizer
PFE: Astellas Pharma Inc.
2018-12-20 09:00:00
Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.